Home -> Law Blog Directory -> Academic Blogs -> Jorda on Trade Secrets
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Academic
: Jorda on Trade Secrets2003 IPO Survey Results: Patent/Trade Secret Complementariness No. 17
Among other specific findings in this IPO Survey anent trade secrets are the following:
All but 6% of responding companies do compete on the basis of proprietary technology.
Loss of trade secret protection would damage 80% of respondents’ ability to sustain their competitive advantage.
All but 3% of respondents build competitive advantage on internally developed know-how.
Only 1/3 of respondents would maintain R&D spending after losing trade secret protection.
Over 2/3 of respondents report that NCAs and NDAs are effective in their industry.
43% of respondents agree that many of their most important ideas cannot be effectively protected with patents due to serious limits to patent protection.
67% of respondents believe that most patents are not thought to be insuperable obstacles and can be invented around.
Two-thirds of respondents agreed that trade secret law is an effective way for them to retain control of important technology.
In light of these results, let no-one treat trade secrets as the “black sheep,” “orphan,” “stepchild,” or “ugly sister” of the intellectual property system, as the members of the “Patent über alles/trade secrets are the cesspool of the patent system” school of thought are wont to do.
Full post as published by Jorda on Trade Secrets on March 14, 2008 (boomark / email).
Trade Secrets
Former execs are hit with doctrine of inevitable disclosure.
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Victoria's Secret
Bras may have caused Woman's Itching, Rash and Welts
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Toyota Recalls 2000-2003 Tundra Vehicles
Toyota Recalls 2000-2003 Tundra Vehicles
Delayed Diagnosis Results in $1.1M Settlement
Delayed Diagnosis Results in $1.1M Settlement>
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Intellectual Property - Trade Secrets Center
BUILDING A PATENT PORTFOLIO STRATEGICALLY: THE COST/BENEFIT ANALYSIS
BIOTECH INDUSTRY CAN BE BENEFITED IF THE TRADE SECRETS ARE USED IN TANDEM WITH THE PATENT PROTECTION
04/24/07 Trade Secret Law: Lydall
Dont Play Mind Games With Trade Secrets








